Legal
Bayer Surges After Roundup Appeal Wins In Philadelphia Court
- Appeals court finds warning claims are trumped by federal law
- Ruling could set up case for review by the US Supreme Court
Bayer has set aside as much as $16 billion to resolve more than 100,000 cases over Roundup.
Photographer: Krisztian Bocsi/BloombergThis article is for subscribers only.
Bayer AG shares jumped following a significant win for the German company in the long-running cancer litigation over its Roundup weedkiller.
A Philadelphia appeals court concluded Thursday that federal regulations governing the pesticide’s warning label supersede Pennsylvania laws under which a Roundup user in the state claimed Bayer’s Monsanto unit should have warned them about cancer risks.